BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from โ10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
ULBI
Ultralife Corporation
There isn't enough reported data to score ULBI yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
ULBI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Weak |
ULBI's revenue and profitability are currently stable, but its cash flow and balance sheet are under pressure.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | โ |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
ULBI PE Valuation
ULBI has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
ULBI Forward outlook
There aren't enough analyst estimates for ULBI to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over ULBI in the latest year-over-year earnings comparison.
ULBI Earnings Per Share
ULBI earned $0.01 per share over the past year, down 97% from the year before.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA has the edge over ULBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
ULBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.3M | +11% |
| Q2 2026 | $47.9M | -1.3% |
| Q1 2026 | $47.4M | -6.5% |
| Q4 2025 | $48.5M | +11% |
| Q3 2025 | $43.4M | +22% |
| Q2 2025 | $48.6M | +13% |
| Q1 2025 | $50.7M | +21% |
| Q4 2024 | $43.9M | -1.6% |
ULBI's revenue has held roughly level: $48M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.6% | +8.8 points |
| Q2 2026 | 7.2% | +2.5 points |
| Q1 2026 | -0.5% | -7.2 points |
| Q4 2025 | -22% | -25 points |
| Q3 2025 | -2.2% | -3.6 points |
| Q2 2025 | 4.7% | -4.5 points |
| Q1 2025 | 6.7% | -3 points |
| Q4 2024 | 3.4% | -4.8 points |
ULBI has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over ULBI on cash generation, producing positive trailing cash flow while its opponent burns cash.
ULBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.5M | -$2.7M |
| Q2 2026 | $735K | -85% |
| Q1 2026 | $1.5M | -40% |
| Q4 2025 | $607K | -75% |
| Q3 2025 | -$797K | -119% |
| Q2 2025 | $4.8M | -44% |
| Q1 2025 | $2.5M | +$2.9M |
| Q4 2024 | $2.4M | +71% |
ULBI's free cash flow was โ$694,000 over the past year, against $9M the year before.
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA has the edge over ULBI on leverage, with a lower net debt burden relative to earnings.
ULBI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 38.3x | High |
| Q3 2025 | 3.6x | Elevated |
| Q2 2025 | 3.2x | Elevated |
| Q1 2025 | 3.2x | Elevated |
| Q4 2024 | 3.4x | Elevated |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | 0.3x | Very low |
| Q1 2024 | 0.9x | Very low |
ULBI's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.4 years a year ago.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
ULBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 82.9 | Overbought |
| Stochastic | 99.6 | Overbought |
ULBI's weekly RSI is 83 (overbought) and its Stochastic is 100 (overbought).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
ULBI PE vs Industrials Sector
| Metric | ULBI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | โ |
ULBI has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
ULBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.76 | 62% above |
| 20 week MA | $7.54 | 109% above |
| 50 week MA | $6.82 | 131% above |
| 100 week MA | $6.76 | 133% above |
| 200 week MA | $7.29 | 116% above |
ULBI has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
ULBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.29 | $6.36 | -13% |
| 2021 | $6.36 | $5.96 | -6.3% |
| 2022 | $5.96 | $3.89 | -35% |
| 2023 | $3.89 | $6.82 | +75% |
| 2024 | $6.82 | $7.29 | +6.9% |
| 2025 | $7.29 | $5.76 | -21% |
| 2026 YTD | $5.76 | $15.8 | +174% |
ULBI has the edge over BA on returns for 2026, with the stronger performance.